Critical Care

Article	Citations
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19	730
Acute respiratory failure in COVID-19: is it “typical” ARDS?	466
COVID-19 pneumonia: ARDS or not?	452
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection	372
The unique characteristics of COVID-19 coagulopathy	346
COVID-19: ICU delirium management during SARS-CoV-2 pandemic	339
Psychological stress of ICU nurses in the time of COVID-19	295
Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis	290
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey	279
Biomarkers of sepsis: time for a reappraisal	277
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China	253
Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients	238
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes	234
Can artificial intelligence help for scientific writing?	234
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients	223
Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis	220
Clinical determinants for fatality of 44,672 patients with COVID-19	201
Ventilator-associated pneumonia in critically ill patients with COVID-19	197
Prediction of the development of acute kidney injury following cardiac surgery by machine learning	190
Emerging SARS-CoV-2 variants of concern and potential intervention approaches	179
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis	178
Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature	177
Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury	170
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19	170
Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics	159

Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies	157
Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients	155
Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic	155
Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study	151
The gut microbiome’s role in the development, maintenance, and outcomes of sepsis	150
Acute kidney injury in SARS-CoV-2 infected patients	148
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China	146
A new clinical trial to test high-dose vitamin C in patients with COVID-19	145
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis	140
Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis	133
The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis	132
Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study	130
High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure	129
SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression	127
Biomarkers for sepsis: more than just fever and leukocytosis—a narrative review	124
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia	124
Neurological manifestations of COVID-19: a systematic review	123
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies	119
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method	116
COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review	115
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain	115
Long-term outcomes after critical illness: recent insights	115
Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients	115
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19	114
Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China	113
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring	108
Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study	108
The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition	106
Dangers of hyperoxia	106
Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients	105
High-density lipoproteins during sepsis: from bench to bedside	105
Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance	104
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series	104
Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis	102
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study	99
Age and sex differences in soluble ACE2 may give insights for COVID-19	99
Lung ultrasound findings in patients with COVID-19 pneumonia	95
Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intens	95
The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study	95
Ethics guidelines on COVID-19 triage—an emerging international consensus	94
Personalized mechanical ventilation in acute respiratory distress syndrome	94
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study	92
Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease	92
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients	90
Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave?	90
Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): international expert consensus	87
Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series	86
Update of the treatment of nosocomial pneumonia in the ICU	85
A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection	85
Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome	85

Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies	84
Prolonged prone position ventilation for SARS-CoV-2 patients is feasible and effective	84
Adjuvant corticosteroid therapy for critically ill patients with COVID-19	83
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study	83
Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series	81
Platelet-derived exosomes promote neutrophil extracellular trap formation during septic shock	81
Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19	80
Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial	80
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series	80
The role of telemedicine during the COVID-19 epidemic in China—experience from Shandong province	79
Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness	79
Brain–heart interaction after acute ischemic stroke	79
Gut-liver crosstalk in sepsis-induced liver injury	79
Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients	78
Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region	78
Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review	78
COVID-19 and the RAAS—a potential role for angiotensin II?	77
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence	76
Molecular mechanisms of sex bias differences in COVID-19 mortality	76
VEGF-D: a novel biomarker for detection of COVID-19 progression	76
Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS	76
Prehospital pulse oximetry: a red flag for early detection of silent hypoxemia in COVID-19 patients	75
Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis	75
Body temperature correlates with mortality in COVID-19 patients	75
Prognostic value of bedside lung ultrasound score in patients with COVID-19	74
Effect of mechanical power on intensive care mortality in ARDS patients	74
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations	72
Blocking IL-1 to prevent respiratory failure in COVID-19	71
Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19	71
How to measure blood pressure using an arterial catheter: a systematic 5-step approach	71
Multimodal non-invasive assessment of intracranial hypertension: an observational study	69
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS	68
COVID-19: a hypothesis regarding the ventilation-perfusion mismatch	67
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)	67
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series	67
Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort	67
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study	66
Right ventricular failure in septic shock: characterization, incidence and impact on fluid responsiveness	65
Bedside calculation of mechanical power during volume- and pressure-controlled mechanical ventilation	65
Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore	65
Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis	64
COVID-19 mortality and ICU admission: the Italian experience	63
The use of venous Doppler to predict adverse kidney events in a general ICU cohort	63
Machine learning model for early prediction of acute kidney injury (AKI) in pediatric critical care	62
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study	62
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients	61
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia	61
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis	61
Machine-learning-based COVID-19 mortality prediction model and identification of patients at low and high risk of dying	60
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial	60
Extracorporeal cardiopulmonary resuscitation in adult patients with out-of-hospital cardiac arrest: a retrospective large cohort multicenter study in Japan	59
Incidence and mortality of pulmonary embolism in COVID-19: a systematic review and meta-analysis	59
Initial antimicrobial management of sepsis	58
Heating, ventilation and air conditioning (HVAC) in intensive care unit	58
Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19	58
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia	57
Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis	57
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs	57
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial	57
Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis	56
Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study	56
Admission decisions to intensive care units in the context of the major COVID-19 outbreak: local guidance from the COVID-19 Paris-region area	56
The effect of higher versus lower protein delivery in critically ill patients: a systematic review and meta-analysis of randomized controlled trials	56
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain	55
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak	55
Timing of antibiotic therapy in the ICU	54
Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia	54
Sepsis is associated with mitochondrial DNA damage and a reduced mitochondrial mass in the kidney of patients with sepsis-AKI	54
Prevalence of post-intensive care syndrome among Japanese intensive care unit patients: a prospective, multicenter, observational J-PICS study	54
ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review	54
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial	53
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia	53
Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis	53
Immune effects of PI3K/Akt/HIF-1α-regulated glycolysis in polymorphonuclear neutrophils during sepsis	53
Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses	52
Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery	52
Large language models and the perils of their hallucinations	51
High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial	51
International variation in the management of severe COVID-19 patients	51
Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surge	50

Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?	50
Hemoperfusion: technical aspects and state of the art	50
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris	50
The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis	50
The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients	50
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis	49
Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic	49
Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study	49
The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial	49
Managing COVID-19 in resource-limited settings: critical care considerations	49
Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study	49
Brain tight junction protein expression in sepsis in an autopsy series	48
Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study	48
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients	48
Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review	48
Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observat	48
The impact of right ventricular injury on the mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis	47
Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19	47
Advanced respiratory monitoring in COVID-19 patients: use less PEEP!	47
Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia	47
A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice	47
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation	47
Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study	47
Causes and characteristics of death in patients with acute hypoxemic respiratory failure and acute respiratory distress syndrome: a retrospective cohort study	46
ECMO during the COVID-19 pandemic: when is it unjustified?	45
Severe Covid-19 disease: rather AVDS than ARDS?	45
Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome	45
Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan	44
Vasopressor Choice and Timing in Vasodilatory Shock	44
Mortality in septic patients treated with vitamin C: a systematic meta-analysis	44
Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study	44
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation	44
Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study	44
Bedside POCUS during ward emergencies is associated with improved diagnosis and outcome: an observational, prospective, controlled study	44
Acute kidney injury in ECMO patients	44
Recommendations for the use of vascular access in the COVID-19 patients: an Italian perspective	43
Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study	43
Restricted visitation policies in acute care settings during the COVID-19 pandemic: a scoping review	43
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients	43
Artificial Intelligence in Critical Care Medicine	43
PEEP levels in COVID-19 pneumonia	43
Plasma exchange in critically ill COVID-19 patients	43
Should we deny ICU admission to the elderly? Ethical considerations in times of COVID-19	42
The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience	42
Recommendations for core critical care ultrasound competencies as a part of specialist training in multidisciplinary intensive care: a framework proposed by the European Society of Intensive Care Medi	41
Venoarterial extracorporeal membrane oxygenation as mechanical circulatory support in adult septic shock: a systematic review and meta-analysis with individual participant data meta-regression analysi	41
Identification and characterization of neutrophil heterogeneity in sepsis	41
Energy delivery guided by indirect calorimetry in critically ill patients: a systematic review and meta-analysis	41
Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation	41
Transcranial Doppler as a screening test to exclude intracranial hypertension in brain-injured patients: the IMPRESSIT-2 prospective multicenter international study	41
Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies	41
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis	41
Intravenous vitamin C administration to patients with septic shock: a pilot randomised controlled trial	41
Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trial	40
Drug dosing in the critically ill obese patient—a focus on sedation, analgesia, and delirium	40
Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis	40
VENTILatOry strategies in patients with severe traumatic brain injury: the VENTILO Survey of the European Society of Intensive Care Medicine (ESICM)	40
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?	40
EXpert consensus On Diaphragm UltraSonography in the critically ill (EXODUS): a Delphi consensus statement on the measurement of diaphragm ultrasound-derived parameters in a critical care setting	40
How COVID-19 pandemic changed our communication with families: losing nonverbal cues	40
Role of endothelial miR-24 in COVID-19 cerebrovascular events	39
Sex differences in survival after out-of-hospital cardiac arrest: a meta-analysis	39
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational st	39
Unmatched ventilation and perfusion measured by electrical impedance tomography predicts the outcome of ARDS	39
The epidemiology and clinical outcomes of ventilator-associated events among 20,769 mechanically ventilated patients at intensive care units: an observational study	39
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients	39
Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study	39
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients	39
Recommendations for hemodynamic monitoring for critically ill children—expert consensus statement issued by the cardiovascular dynamics section of the European Society of Paediatric and Neonatal Inten	39
Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?	39
“War to the knife” against thromboinflammation to protect endothelial function of COVID-19 patients	38
A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality	38
Early individualized positive end-expiratory pressure guided by electrical impedance tomography in acute respiratory distress syndrome: a randomized controlled clinical trial	38
Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort	38
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study	38
Extracorporeal versus conventional cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: a secondary analysis of the Prague OHCA trial	38
Development of a work of breathing scale and monitoring need of intubation in COVID-19 pneumonia	38
The fluid challenge	38
Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis	38
Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care	37
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients	37
Different applications of the KDIGO criteria for AKI lead to different incidences in critically ill patients: a post hoc analysis from the prospective observational SICS-II study	37
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study	37
Association between mean arterial pressure during the first 24 hours and hospital mortality in patients with cardiogenic shock	37
Significance of body temperature in elderly patients with sepsis	37
Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study	37
Severe pulmonary embolism in COVID-19 patients: a call for increased awareness	37
Frailty, delirium and hospital mortality of older adults admitted to intensive care: the Delirium (Deli) in ICU study	37
Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis	37
Brain–lung interactions and mechanical ventilation in patients with isolated brain injury	37
Efficacy of tocilizumab treatment in severely ill COVID-19 patients	36
Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients	36
Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients	36
Effect of favipiravir and an anti-inflammatory strategy for COVID-19	36
Postoperative hypotension in patients discharged to the intensive care unit after non-cardiac surgery is associated with adverse clinical outcomes	36